Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection
NCT07279792 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2025-12-29
Summary
This randomized controlled trial will evaluate the efficacy of three bladder irrigation solutions - distilled water (DW), normal saline (NS), and hypertonic saline (HS) - as continuous bladder irrigation (CBI) following transurethral resection of non-muscle invasive bladder cancer (NMIBC). Short term (6 months) recurrence and progression free survival are mainly evaluated.
Conditions
- Bladder (Urothelial, Transitional Cell) Cancer
- Nonmuscle Invasive Bladder Cancer
- Irrigation
- Hypertonic Saline
- Normal Saline
- Distilled Water
Interventions
- DRUG
-
Continuous Bladder Irrigation with distilled water
Continuous Bladder Irrigation with distilled water post non muscle invasive bladder cancer urethral resection by endoscopy
- DRUG
-
Continuous Bladder Irrigation with normal saline
Continuous Bladder Irrigation with normal saline post non muscle invasive bladder cancer urethral resection by endoscopy
- DRUG
-
Continuous Bladder Irrigation with hypertonic saline
Continuous Bladder Irrigation with hypertonic saline post non muscle invasive bladder cancer urethral resection by endoscopy
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2025-08-01
- Completion
- 2025-09-01
Countries
- Egypt
Study Locations
More Related Trials
-
Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection
NCT04147182 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
NCT04617743 ·Status: UNKNOWN
-
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
NCT07036731 ·Status: RECRUITING ·Phase: NA
-
Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
NCT04865939 ·Status: RECRUITING ·Phase: PHASE3
-
A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)
NCT01799499 ·Status: WITHDRAWN ·Phase: NA
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA
-
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
NCT07187635 ·Status: RECRUITING ·Phase: NA
-
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
NCT02716961 ·Status: UNKNOWN ·Phase: NA
-
Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer
NCT07272603 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
NCT06287541 ·Status: RECRUITING ·Phase: NA
-
Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.
NCT07259798 ·Status: COMPLETED ·Phase: NA
-
Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder
NCT05077852 ·Status: UNKNOWN
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
Intravesical Adjuvant Electromotive Mitomycin-C
NCT01920269 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
NCT02992990 ·Status: UNKNOWN ·Phase: NA
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
NCT05146635 ·Status: UNKNOWN ·Phase: NA
-
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NCT07180212 ·Status: RECRUITING ·Phase: NA
-
The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
NCT07130578 ·Status: RECRUITING
-
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
NCT06696794 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
NCT02443844 ·Status: UNKNOWN ·Phase: PHASE4
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.
NCT04603612 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
NCT05626101 ·Status: RECRUITING ·Phase: NA
-
Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer
NCT06818799 ·Status: COMPLETED ·Phase: NA